SNX10 and glioblastoma: Furthermore, SNX10 expression levels negatively correlated with prognosis of glioblastoma patients in TCGA, CGGA and Gravendeel glioblastoma data sets, including in analyses restricted to patients with wild-type IDH1 (Figure 12, H–J, and Supplemental Figure 5D).